Loading...

Hiroki Nakaoka, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
DepartmentRadiation Oncology
Address1450 Third St
San Francisco CA 94158
Emailhiroki.nakaoka@ucsf.edu
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    The University of Tokyo, JAPANPh.D06/2016Cancer Cell Biology

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hara T, Nakaoka H, Hayashi T, Mimura K, Hoshino D, Inoue M, Nagamura F, Murakami Y, Seiki M, Sakamoto T. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes. Proc Natl Acad Sci U S A. 2017 05 30; 114(22):E4416-E4424. PMID: 28507122.
      View in: PubMed
    2. Nakaoka H, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M, Murakami Y, Sakamoto T. Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth. Oncogenesis. 2017 May 15; 6(5):e334. PMID: 28504692.
      View in: PubMed
    3. Uematsu T, Fujita T, Nakaoka H, Hara T, Kobayashi N, Murakami Y, Seiki M, Sakamoto T. Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus. Sci Rep. 2016 11 24; 6:37815. PMID: 27883071.
      View in: PubMed
    4. Ito T, Matsubara D, Tanaka I, Makiya K, Tanei ZI, Kumagai Y, Shiu SJ, Nakaoka H, Ishikawa S, Isagawa T, Morikawa T, Shinozaki-Ushiku A, Goto Y, Nakano T, Tsuchiya T, Tsubochi H, Komura D, Aburatani H, Dobashi Y, Nakajima J, Endo S, Fukayama M, Sekido Y, Niki T, Murakami Y. Loss of YAP1 defines neuroendocrine differentiation of lung tumors. Cancer Sci. 2016 Oct; 107(10):1527-1538. PMID: 27418196.
      View in: PubMed
    5. Yoshino S, Hara T, Nakaoka H, Kanamori A, Murakami Y, Seiki M, Sakamoto T. The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux. Cell Discov. 2016; 2:16019. PMID: 27462466; PMCID: PMC4960523.
    6. Nakaoka H, Hara T, Yoshino S, Kanamori A, Matsui Y, Shimamura T, Sato H, Murakami Y, Seiki M, Sakamoto T. NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells. Sci Rep. 2016 Mar 07; 6:22784. PMID: 26948053; PMCID: PMC4780031.